PharmaShots | Incisive News in 3 Shots

Subscribe Now

repare therapeutics

Repare Therapeutics Reports the P-I (MYTHIC) Trial Data of Lunresertib Plus Camonsertib to Treat Gynecologic Cancers

Repare Therapeutics Reports the P-I (MYTHIC) Trial Data of Lunresertib Plus Camonsertib to Treat Gynecologic Cancers

December 13, 2024

Repare Therapeutics Presents Initial Clinical P-I/II Trial (TRESR) and (ATTACC) Results of Camonsertib + Three PARP Inhibitors for Solid Tumors at AACR 2023

Repare Therapeutics Presents Initial Clinical P-I/II Trial (TRESR) and (ATTACC) Results of Camonsertib + Three PARP Inhibitors for...

April 19, 2023

PharmaShots' Most Read News of 2019

PharmaShots' Most Read News of 2019

January 10, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us